Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized open-label trial of intra-articular TNP-2092 for prosthetic joint infection
CTR20263531Phase 2Active
- Sponsor
- TenNor Therapeutics
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaquizinone in periprosthetic joint infection (PJI), sponsored by TenNor Therapeutics. Started Sep 2026; status: active.
02
Drugs
rifaquizinone
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on CTR20263531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263531.